Summary
GLAXO boss Jean-Pierre Garnier is raising the stakes in the drugs giant's battle with US regulators, accusing them of 'bullying' and even 'extortion'.
And the company was able to offer shareholders some good news, after days of disastrous headlines, by announcing positive results from the latest Phase II clinical trials of its breast cancer treatment lapatinib.See the full content of this document
Extract
Glaxo Blasts 'Bully' Spitzer
But new trouble is looming after the UK drugs regul...
See the full content of this document
Sponsored links
